Karel Fišer

1.4k total citations
40 papers, 704 citations indexed

About

Karel Fišer is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Karel Fišer has authored 40 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Public Health, Environmental and Occupational Health and 8 papers in Hematology. Recurrent topics in Karel Fišer's work include Acute Lymphoblastic Leukemia research (10 papers), Single-cell and spatial transcriptomics (9 papers) and Acute Myeloid Leukemia Research (7 papers). Karel Fišer is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Single-cell and spatial transcriptomics (9 papers) and Acute Myeloid Leukemia Research (7 papers). Karel Fišer collaborates with scholars based in Czechia, United Kingdom and Germany. Karel Fišer's co-authors include Josef Vormoor, Olaf Heidenreich, Simon Bomken, Jan Trka, Markéta Žaliová, Jan Stuchlý, Júlia Starková, Jan Starý, Alena Musilová and Ondřej Hrušák and has published in prestigious journals such as Nature Communications, Blood and Bioinformatics.

In The Last Decade

Karel Fišer

38 papers receiving 695 citations

Peers

Countries citing papers authored by Karel Fišer

Since Specialization

Citations

This map shows the geographic impact of Karel Fišer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karel Fišer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karel Fišer more than expected).

Fields of papers citing papers by Karel Fišer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karel Fišer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karel Fišer. The network helps show where Karel Fišer may publish in the future.

Co-authorship network of co-authors of Karel Fišer

This figure shows the co-authorship network connecting the top 25 collaborators of Karel Fišer. A scholar is included among the top collaborators of Karel Fišer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karel Fišer. Karel Fišer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative 2022 ·Frontiers in Immunology ·(unknown), (unknown), Pei M. Aui, Javier Fernández, Karel Fišer, Pablo Engel, Menno C. van Zelm, Tomáš Kalina	11
2	Nucleoporin TPR Affects C2C12 Myogenic Differentiation via Regulation of Myh4 Expression 2021 ·Cells ·(unknown), (unknown), Karel Fišer, Tomáš Sieger, Jindřiška Fišerová, Pavel Hozák	3
3	<i>DUX4r</i>, <i>ZNF384r</i> and <i>PAX5</i>-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch 2020 ·Haematologica ·Michaela Nováková, Markéta Žaliová, Karel Fišer, (unknown), (unknown), Alena Musilová, Monika Brüggemann, Matthias Ritgen, Eva Froňková, Tomáš Kalina, Jan Starý, (unknown), Peter Švec, Alexandra Kolenová, Jan Stuchlý, Jan Zuna, Jan Trka, Ondřej Hrušák, Ester Mejstříková	32
4	ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity 2019 ·Haematologica ·Markéta Žaliová, Eliška Potůčková, (unknown), Alena Musilová, (unknown), Karel Fišer, Jan Stuchlý, Ester Mejstříková, Júlia Starková, Jan Zuna, Jan Starý, Jan Trka	31
5	Nuclear pore protein TPR associates with lamin B1 and affects nuclear lamina organization and nuclear pore distribution 2019 ·Cellular and Molecular Life Sciences ·Jindřiška Fišerová, (unknown), Tomáš Sieger, (unknown), (unknown), (unknown), Martin Čapek, Karel Fišer, Pavel Hozák	20
6	Toll-like receptor 2 expression on c-kit+ cells tracks the emergence of embryonic definitive hematopoietic progenitors 2019 ·Nature Communications ·(unknown), (unknown), (unknown), Michal Kolář, Karel Fišer, Jan Procházka, Radislav Sedláček, Andrea Jurisicova, Hoon‐Ki Sung, Vladimír Kořínek, Meritxell Alberich-Jordà, Isabelle Godin, Dominik Filipp	9
7	CD Maps—Dynamic Profiling of CD1–CD100 Surface Expression on Human Leukocyte and Lymphocyte Subsets 2019 ·Frontiers in Immunology ·Tomáš Kalina, Karel Fišer, Martín Pérez‐Andrés, (unknown), Marta Cuenca, Sophinus J. W. Bartol, Elena Blanco, Pablo Engel, Menno C. van Zelm	48
8	Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort 2019 ·Haematologica ·Markéta Žaliová, Jan Stuchlý, (unknown), Alena Musilová, Karel Fišer, (unknown), Júlia Starková, Martina Vašková, Ondřej Hrušák, Lucie Šrámková, Jan Starý, Jan Zuna, Jan Trka	71
9	High-Content Immunophenotyping and Hierarchical Clustering Reveal Sources of Heterogeneity and New Surface Markers of Human Blood Monocyte Subsets 2019 ·Thrombosis and Haemostasis ·Jedrzej Hoffmann, Karel Fišer, Christoph Liebetrau, (unknown), David Kost, Sandra Voss, (unknown), Oliver Dörr, Christoph Lipps, Holger Nef, Helge Möllmann, Christian W. Hamm, Till Keller, Christian Troidl	12
10	flowIO: Flow cytometry standard conformance testing, editing, and export tool 2018 ·Cytometry Part A ·(unknown), (unknown), Karel Fišer	7
11	What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics 2017 ·PLoS Pathogens ·(unknown), Václav Čapek, Karel Fišer, (unknown), Pavel Dřevı́nek	23
12	Low HOX gene expression in PML-RARα- positive leukemia results from suppressed histone demethylation 2017 ·Epigenetics ·(unknown), Alena Musilová, (unknown), Markéta Žaliová, Karel Fišer, Meritxell Alberich-Jordà, Jan Trka, Júlia Starková	13
13	High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells 2016 ·Molecular & Cellular Proteomics ·Veronika Kanderová, (unknown), Jan Stuchlý, Martina Vašková, Tomáš Brdička, Karel Fišer, Ondřej Hrušák, Fridtjof Lund‐Johansen, Tomáš Kalina	10
14	Mantle cell lymphoma‐variant Richter syndrome: Detailed molecular‐cytogenetic and backtracking analysis reveals slow evolution of a pre‐MCL clone in parallel with CLL over several years 2016 ·International Journal of Cancer ·Pavel Klener, Eva Froňková, Adéla Berková, Radek Jakša, (unknown), Kristina Forsterová, J. Soukup, Vojtěch Kulvait, (unknown), Karel Fišer, Dana Průková, Md. Mahmudul Alam, (unknown), K Michalová, Zuzana Zemanová, (unknown), Šoňa Peková, Marek Trněný	9
15	Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells 2015 ·Leukemia ·Ivana Heřmanová, Amaia Arruabarrena-Aristorena, Karel Vališ, Hana Nůsková, Meritxell Alberich-Jordà, Karel Fišer, Sonia Fernández‐Ruiz, Daniel Kavan, Alena Pecinová, Mireia Niso‐Santano, Markéta Žaliová, Petr Novák, J Houštěk, Tomáš Mráček, Guido Kroemer, Arkaitz Carracedo, Jan Trka, Júlia Starková	38
16	Quantitative expression of regulatory and differentiation-related genes in the key steps of human hematopoiesis: The LeukoStage Database 2015 ·Differentiation ·(unknown), Martina Vašková, Eva Froňková, (unknown), Tomáš Kalina, Ester Mejstříková, (unknown), Karel Fišer, Ondřej Hrušák	4
17	High-Throughput 13-Parameter Immunophenotyping Identifies Shifts in the Circulating T-Cell Compartment Following Reperfusion in Patients with Acute Myocardial Infarction 2012 ·PLoS ONE ·Jedrzej Hoffmann, Karel Fišer, Jolanta U. Weaver, Ian Dimmick, (unknown), Hanspeter Pircher, Carmen Martín-Ruiz, Murugapathy Veerasamy, Bernard Keavney, Thomas von Zglinicki, Ioakim Spyridopoulos	41
18	An automated analysis of highly complex flow cytometry‐based proteomic data 2011 ·Cytometry Part A ·Jan Stuchlý, Veronika Kanderová, Karel Fišer, (unknown), Anders Holm, Weiwei Wu, Ondřej Hrušák, Fridtjof Lund‐Johansen, Tomáš Kalina	10
19	Understanding the cancer stem cell 2010 ·British Journal of Cancer ·Simon Bomken, Karel Fišer, Olaf Heidenreich, Josef Vormoor	161
20	The radiation of polarized matter in a wave-guide of general cross-section with two dielectrics part one 1979 ·Czechoslovak Journal of Physics ·Karel Fišer, David R. Novotny	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact